Dr. Tom Mihaljevic and Cleveland Clinic Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

Cleveland Clinic (CC) 2021 operating revenue: $12.5 billion (Exhibit 1).
Operating margin: 2.1% in 2021, down from 3.3% in 2020 (Exhibit 1).
Clinical volume: Over 10 million patient visits across 20+ hospitals (Paragraph 4).
Capital expenditure: Significant investment required for digital transformation and global expansion (Paragraph 12).

Operational Facts

Leadership: Dr. Tom Mihaljevic, CEO, initiated a One Clinic strategy (Paragraph 2).
Organizational structure: Historically decentralized; shift toward integrated, physician-led governance (Paragraph 5).
Global footprint: Facilities in Ohio, Florida, Nevada, Toronto, Abu Dhabi, and London (Exhibit 3).
Workforce: Over 70,000 caregivers; high emphasis on patient experience and clinical outcomes (Paragraph 8).

Stakeholder Positions

Dr. Tom Mihaljevic: Focus on growth, digital health, and standardized care delivery across all sites (Paragraph 3).
Physician leadership: Concerned with balancing autonomy with the One Clinic mandate (Paragraph 9).
Patients: Expectation of identical high-quality outcomes regardless of geography (Paragraph 11).

Information Gaps

Specific cost-benefit analysis of the international expansion versus domestic margin pressures.
Quantified impact of the One Clinic initiative on administrative overhead reduction.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How does Cleveland Clinic achieve global scale while maintaining the clinical quality and cultural identity that define its brand, specifically amid margin compression?

Structural Analysis

Value Chain: The primary value proposition is clinical excellence. Expanding the footprint risks diluting this if clinical standards are not perfectly replicated.
Porter’s Five Forces: Rivalry among academic medical centers is fierce. Buyer power is increasing as payers demand data-driven outcomes.

Strategic Options

Option 1: Aggressive Global Scaling. Prioritize rapid entry into high-growth international markets. Trade-off: High capital demand; risk of operational drift.
Option 2: Margin-Focused Domestic Consolidation. Pause international expansion to optimize domestic operations and implement digital efficiencies. Trade-off: Cedes market share to competitors; limits long-term growth.
Option 3: The Integrated Model (Recommended). Standardize clinical outcomes via digital health and a unified physician governance structure before further physical expansion. Rationale: Protects the brand while creating a scalable template for future growth.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

Governance Alignment: Finalize the One Clinic physician leadership structure (Months 1-3).
Digital Infrastructure: Deploy a unified electronic health record (EHR) and data analytics platform across all domestic and international sites (Months 4-12).
Clinical Standardization: Implement mandatory care protocols for top 20 high-acuity procedures (Months 6-18).

Key Constraints

Physician Buy-in: The transition to standardized protocols faces resistance from clinicians accustomed to total autonomy.
Data Integration: Regulatory hurdles regarding patient data privacy across international jurisdictions.

Risk-Adjusted Strategy

Build a 15% contingency into the digital deployment timeline to account for local regulatory delays in international markets.

4. Executive Review and BLUF (Executive Critic)

BLUF

Cleveland Clinic must stop treating global expansion as a volume play and redefine it as a knowledge export business. The current 2.1% margin is too thin to support a geographically dispersed, capital-intensive model if clinical quality falters. The organization should prioritize the digitization of its clinical protocols into a proprietary, exportable system. Once this intellectual property is standardized and scalable, international growth should move to an asset-light model—management contracts and licensing—rather than physical ownership. This shifts the risk from the balance sheet to the brand.

Dangerous Assumption

The analysis assumes that clinical excellence is portable through digital tools alone. In reality, the culture of care at the Cleveland Clinic is rooted in tacit knowledge held by staff, which cannot be captured by an EHR. The risk of culture dilution is the primary threat to the brand.

Unaddressed Risks

Regulatory/Political Risk: International facilities are subject to shifting government policies in the UAE and UK, which could lead to sudden asset devaluation.
Talent Retention: If the One Clinic mandate is perceived as overly bureaucratic, the top-tier medical talent that drives the brand will migrate to competing academic centers.

Unconsidered Alternative

The team failed to consider a divestment or partnership strategy for underperforming domestic assets to fund the digital transformation, focusing instead on internal efficiency gains.